Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Key Patent For Amarin's Blockbuster Drug May Lead To New Highs
Seeking Alpha
Wednesday, March 21, 2012 - 11:23am
tags:
patents, Amarin, AMR101
Glaxo Joins J&J in $200 Million Fund With Index Ventures
Bloomberg
Wednesday, March 21, 2012 - 10:06am
tags:
GSK, JNJ, venture capital
Why Pfizer, Bristol And Mylan Will Skyrocket
Seeking Alpha
Wednesday, March 21, 2012 - 10:05am
tags:
Pfizer, Mylan, Bristol-Myers Squibb
The Best High Dividend Pharma Stocks
Motley Fool
Wednesday, March 21, 2012 - 10:05am
tags:
dividends, AstraZeneca, Pfizer, Sanofi, Merck, Eli Lilly, GSK
FDA panel does not recommend Taltorvic
Reuters
Wednesday, March 21, 2012 - 10:03am
tags:
soft tissue sarcomas, FDA, advisory panels, Taltorvic, Merck, Ariad Pharmaceuticals
FDA panel recommends Glaxo's Votrient for sarcoma
Yahoo/Reuters
Wednesday, March 21, 2012 - 10:02am
tags:
FDA, advisory panel, Votrient, sarcoma, GSK
Protalix: What You Need To Know Ahead Of The May 1 PDUFA Date
Seeking Alpha
Wednesday, March 21, 2012 - 10:01am
tags:
FDA, Pfizer, Sanofi, Shire, taliglucerase alfa, Gaucher disease, Protalix BioTherapeutics
EASL Gives Wall Street's Privileged Investors Sneaky Preview to Key Hep C Data
TheStreet.com
Tuesday, March 20, 2012 - 11:47am
tags:
hepatitis C, EASL, Gilead, Bristol-Myers Squibb, Abbott Laboratories, Vertex, Merck
3 Hot Pharmas With Skin In The Game
Seeking Alpha
Tuesday, March 20, 2012 - 10:40am
tags:
DUSA pharmaceuticals, Anika, Obagi Medical Products, anti-aging
Roche takes its case to Illumina shareholders
Reuters
Tuesday, March 20, 2012 - 10:37am
tags:
Roche, Illumina, M&A
Loss at XOMA Wider Than Expected
Yahoo/Zacks
Tuesday, March 20, 2012 - 10:36am
tags:
earnings, Xoma
Cyclacel: An Intriguing Long Shot
Seeking Alpha
Tuesday, March 20, 2012 - 10:35am
tags:
Cyclacel, Sapacitabine, cancer, Daiichi Sankyo
Why Bristol-Myers Squibb's Earnings Are Outstanding
Motley Fool
Tuesday, March 20, 2012 - 10:34am
tags:
earning, Bristol-Myers Squibb
Eli Lilly to Focus on Cancer, Diabetes in China, CEO Says
Bloomberg
Tuesday, March 20, 2012 - 10:31am
tags:
Eli Lilly, cancer, diabetes, Pharma CEOs, China, John Lechleiter
AstraZeneca Won’t Seek Approval for Targacept Antidepressant
Bloomberg
Tuesday, March 20, 2012 - 10:18am
tags:
Targacept, antidepressants, AstraZeneca
Pfizer’s Rheumatoid Arthritis Pill: Not A Slam Dunk
Pharmalot
Tuesday, March 20, 2012 - 10:17am
tags:
Pfizer, rheumatoid arthritis, tofacitinib
Pozen's Final Results On Ulcer Safe Aspirin Can Send Shares Soaring
Seeking Alpha
Tuesday, March 20, 2012 - 10:15am
tags:
Pozen, asprin, ulcers, PA32540
Neurocrine Could Be A Major Biotech Comeback Story
Seeking Alpha
Tuesday, March 20, 2012 - 10:14am
tags:
Neurocrine, Abbott Laboratories, GSK
For Sale: Pfizer's Growth Prospects
Seeking Alpha
Tuesday, March 20, 2012 - 10:11am
tags:
Pfizer
An FDA Advisory Panel Doubleheader
Motley Fool
Tuesday, March 20, 2012 - 10:07am
tags:
FDA, advisory panels, Votrient, soft tissue sarcomas, GSK, Merck, ridaforolimus, Ariad Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.